3-{(E)-[(4-fluorophenyl)imino]methyl}phenol

3-{(E)-[(4-Fluorophenyl)imino]methyl}phenol is a benzylated phenolic compound featuring a 4-fluorophenyl group linked via a (E)-configured imino methylene bridge to a hydroxybenzene ring. The (E) stereochemistry at the C=N double bond and the para-fluoro substitution define its structural distinctiveness. This impurity arises from a nucleophilic aromatic substitution pathway during Ezetimibe synthesis, where the fluorinated aromatic competes with the parent drug's precursor. It serves as a critical HPLC reference standard for quantifying process-related impurities in Ezetimibe active pharmaceutical ingredients.